Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Lilly Icos seeks FDA approval of Cialis for erectile dysfunction

June 29, 2001

Milkhaus begins clinical testing of ML-04 for chronic prostatitis

June 29, 2001

Sepracor evaluates sustained-release formulation of (S)-oxybutynin in phase III

June 21, 2001

Milkhaus expands clinical testing of BPH agent

June 19, 2001

High response rate and rapid and sustained responsiveness reported for Cialis in ED

June 14, 2001

Oral desmopressin may have role in nocturia according to AUA presentations

June 14, 2001

Ivax set to begin phase II study of GYKI-16084 for BPH

June 14, 2001

New prostaglandin derivatives useful for nephropathies and cardiovascular diseases

June 13, 2001

Rapid and progressive response to Elmiron reported in IC patients at AUA meeting

June 13, 2001

Once-daily Ditropan XL receives clearance in Canada

June 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...